Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group

With the development of modern solid-phase assays to detect anti-HLA antibodies and a more precise histological classification, the diagnosis of antibody-mediated rejection (AMR) has become more common and is a major cause of kidney graft loss. Currently, there are no approved therapies and treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Schinstock, Carrie A., Mannon, Roslyn B., Budde, Klemens, Chong, Anita S., Haas, Mark, Knechtle, Stuart, Lefaucheur, Carmen, Montgomery, Robert A., Nickerson, Peter, Tullius, Stefan G., Ahn, Curie, Askar, Medhat, Crespo, Marta, Chadban, Steven J., Feng, Sandy, Jordan, Stanley C., Man, Kwan, Mengel, Michael, Morris, Randall E., O’Doherty, Inish, Ozdemir, Binnaz H., Seron, Daniel, Tambur, Anat R., Tanabe, Kazunari, Taupin, Jean-Luc, O’Connell, Philip J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176344/
https://www.ncbi.nlm.nih.gov/pubmed/31895348
http://dx.doi.org/10.1097/TP.0000000000003095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176344/
https://www.ncbi.nlm.nih.gov/pubmed/31895348
http://dx.doi.org/10.1097/TP.0000000000003095

Ejemplares similares